Moreover, CD4+ T cells may also exert antitumor effects by assisting CD8+ T cells or, in some cases, directly recognizing antigens presented on the surface of tumor cells eventually followed by secretion of type 1 cytokines (TNF-α or IFN-γ) or direct cancer killing [16, 17]. Here, CD8A is linked to neoplasm.